Previous studies have highlighted a role for BTLA in airway inflammation, but to the best of our knowledge, our study demonstrates for the first time the role of BTLA in steroid-resistant asthma through a mechanism by which BTLA enhancement attenuates Th17 number and activity by downregulating NF-κB signaling. This evidence concerns the gene NFKB1 and asthma.